Role of angiotensin II receptor subtype activation in cognitive function and ischaemic brain damage

British Journal of Pharmacology

Volumn 163, Issue 6, 2011, Pages 1122-1130

  Horiuchi, Masatsugu ^a   Mogi, Masaki ^a  

^a EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

angiotensin II; cognitive impairment; hypertension; receptor; stroke

Indexed keywords

1 (4 AMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDROIMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; 1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN RECEPTOR; ANGIOTENSIN RECEPTOR ANTAGONIST; COMPOUND 21; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HORMONE RECEPTOR STIMULATING AGENT; HYDRALAZINE; NICOTINOYLTYROSYL(N BENZYLOXYCARBONYLARGINYL)LYSYLHISTIDYLPROLYLISOLEUCINE; OLMESARTAN; TELMISARTAN; UNCLASSIFIED DRUG; VALSARTAN;

ALZHEIMER DISEASE; BRAIN BLOOD FLOW; BRAIN ISCHEMIA; COGNITION; COGNITIVE DEFECT; DEMENTIA; DRUG EFFECT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HYPERTENSION; NERVE FIBER GROWTH; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; RECEPTOR BLOCKING; REVIEW; STROKE;

BRAIN ISCHEMIA; CEREBRUM; HUMANS; RECEPTOR, ANGIOTENSIN, TYPE 1; RENIN-ANGIOTENSIN SYSTEM; STROKE;

EID: 79959736871     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2010.01167.x     Document Type: Review

References (83)

1. Alexander SP, Mathie A, Peters JA, (2009). Guide to Receptors and Channels (GRAC), 4th edition. Br J Pharmacol 158 (Suppl. 1): S1-S254.
2. Benson SC, Pershadsingh HA, Ho CI, Chittiboyina A, Desai P, Pravenec M, et al,. (2004). Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARgamma-modulating activity. Hypertension 43: 993-1002. (Pubitemid 38579904)
3. Bosnyak S, Welungoda IK, Hallberg A, Alterman M, Widdop RE, Jones ES, (2010). Stimulation of angiotensin AT2 receptors by the non-peptide agonist, Compound 21, evokes vasodepressor effects in conscious spontaneously hypertensive rats. Br J Pharmacol 159: 709-716.
4. Camacho IE, Serneels L, Spittaels K, Merchiers P, Dominguez D, De Strooper B, (2004). Peroxisome-proliferator-activated receptor gamma induces a clearance mechanism for the amyloid-beta peptide. J Neurosci 24: 10908-10917. (Pubitemid 39602402)
5. Chan PH, (2001). Reactive oxygen radicals in signaling and damage in the ischemic brain. J Cereb Blood Flow Metab 21: 2-14. (Pubitemid 32036708)
6. Cote F, Do TH, Laflamme L, Gallo JM, Gallo-Payet N, (1999). Activation of the AT(2) receptor of angiotensin II induces neurite outgrowth and cell migration in microexplant cultures of the cerebellum. J Biol Chem 274: 31686-31692.
7. Cote F, Laflamme L, Payet MD, Gallo-Payet N, (1998). Nitric oxide, a new second messenger involved in the action of angiotensin II on neuronal differentiation of NG108-15 cells. Endocr Res 24: 403-407. (Pubitemid 29016414)
8. Dahlöf B, Devereux RB, Kjeldsen SE, Julius S, Beevers G, de Faire U, et al,.; LIFE Study Group (2002). Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertensive study (LIFE); a randomised trial against atenolol. Lancet 359: 995-1003. (Pubitemid 34286536)
9. Davisson RL, Yang G, Beltz TG, Cassell MD, Jhonson AK, Sigmund CD, (1998). The brain renin-angiotensin system contributes to the hypertension in mice containing both the human renin and human angiotensinogen transgenes. Circ Res 83: 1047-1058. (Pubitemid 28520934)
10. Davisson RL, Oliverio MI, Coffman TM, Sigmund CD, (2000). Divergent functions of angiotensin II receptor isoforms in the brain. J Clin Invest 106: 103-106. (Pubitemid 30437245)
11. Dias-Santagata D, Fulga TA, Duttaroy A, Feany MB, (2007). Oxidative stress mediates tau-induced neurodegeneration in Drosophila. J Clin Invest 117: 236-245. (Pubitemid 46055207)
12. Didion SP, Sigmund CD, Faraci FM, (2000). Impaired endothelial function in transgenic mice expressing both human renin and human angiotensinogen. Stroke 31: 760-765. (Pubitemid 30131667)
13. Engelhorn T, Goerike S, Doerfler A, Okorn C, Forsting M, Heusch G, et al,. (2004). The angiotensin II type 1-receptor blocker candesartan increases cerebral blood flow, reduces infarct size, and improves neurologic outcome after transient cerebral ischemia in rats. J Cereb Blood Flow Metab 24: 467-474. (Pubitemid 38455442)
14. Franci FM, Lamping KG, Modrick ML, Ryan MJ, Sigmund CD, Didion SP, (2006). Cerebral vascular effects of angiotensin II: new insights from genetic models. J Cereb Blood Flow Metab 26: 449-455.
15. Fuentes B, Fernández-Domínguez J, Ortega-Casarrubios MA, SanJosé B, Martínez-Sánchez P, Díez-Tejedor E, (2010). Treatment with angiotensin receptor blockers before stroke could exert a favourable effect in acute cerebral infarction. J Hypertens 28: 575-581.
16. Fukamizu A, Sugimura K, Takimoto E, Sugiyama F, Seo MS, Takahashi S, et al,. (1993). Chimeric renin-angiotensin system demonstrates sustained increase in blood pressure of transgenic mice carrying both human renin and human angiotensinogen genes. J Biol Chem 268: 11617-11621. (Pubitemid 23168109)
17. de Gasparo M, Catt KJ, Inagami T, Wright JW, Unger T, (2000). International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev 52: 415-472.
18. Gelosa P, Pignieri A, Fandriks L, de Gasparo M, Hallberg A, Banfi C, et al,. (2009). Stimulation of AT2 receptor exerts beneficial effects in stroke-prone rats: focus on renal damage. J Hypertens 27: 2444-2451.
19. Gendron L, Laflamme L, Rivard N, Asselin C, Payet MD, Gallo-Payet N, (1999). Signals from the AT2 (angiotensin type 2) receptor of angiotensin II inhibit p21ras and activate MAPK (mitogen-activated protein kinase) to induce morphological neuronal differentiation in NG108-15 cells. Mol Endocrinol 13: 1615-1626. (Pubitemid 30650600)
20. Hamai M, Iwai M, Ide A, Tomochika H, Tomono Y, Mogi M, et al,. (2006). Comparison of inhibitory action of candesartan and enalapril on brain ischemia through inhibition of oxidative stress. Neuropharmacology 51: 822-828. (Pubitemid 44376401)
21. Hayashi J, Takagi Y, Fukuda H, Imazato T, Nishimura M, Fujimoto M, et al,. (2006). Primate embryonic stem cell-derived neuronal progenitors transplanted into ischemic brain. J Cereb Blood Flow Metab 26: 906-914. (Pubitemid 43980407)
22. Hofsaess U, Kapfhammer JP, (2003). Identification of numerous genes differentially expressed in rat brain during postnatal development by suppression subtractive hybridization and expression analysis of the novel rat gene rMMS2. Brain Res Mol Brain Res 113: 13-27. (Pubitemid 36579062)
23. Horiuchi M, Akishita M, Dzau VJ, (1999). Recent progress in angiotensin II type 2 receptor research in the cardiovascular system. Hypertension 33: 613-621. (Pubitemid 29091636)
24. Inaba S, Iwai M, Furuno M, Tomono Y, Kanno H, Senba I, et al,. (2009a). Continuous activation of renin-angiotensin system impairs cognitive function in renin/angiotensinogen transgenic mice. Hypertension 53: 356-362.
25. Inaba S, Iwai M, Tomono Y, Senba I, Furuno M, Kanno H, et al,. (2009b). Exaggeration of focal cerebral ischemia in transgenic mice carrying human renin and human angiotensinogen genes. Stroke 40: 597-603.
26. 1 antagonist. Stroke 33: 2297-2303. (Pubitemid 35014646)
27. Iwai M, Liu HW, Chen R, Ide A, Okamoto S, Hata R, et al,. (2004). Possible inhibition of focal cerebral ischemia by angiotensin II type 2 receptor stimulation. Circulation 110: 843-848. (Pubitemid 39096013)
28. Iwanami J, Mogi M, Li JM, Tsukuda K, Min LJ, Sakata A, et al,. (2008). Deletion of angiotensin II type 2 receptor attenuates protective effects of bone marrow stromal cell treatment on ischemia-reperfusion brain injury in mice. Stroke 39: 2554-2559.
29. Iwanami J, Mogi M, Tsukuda K, Min LJ, Sakata A, Jing F, et al,. (2010). Low dose of telmisartan prevents ischemic brain damage with peroxisome proliferator-activated receptor-gamma activation in diabetic mice. J Hypertens 28: 1730-1737.
30. Jöhren O, Imboden H, Häuser W, Maye I, Sanvitto GL, Saavedra JM, (1997). Localization of angiotensin-covertingenzyme, angiotensin II, angiotensin II receptor subtypes, and vasopressin in the mouse hypothalamus. Brain Res 757: 218-227. (Pubitemid 27244600)
31. Kaschina E, Grzesiak A, Li J, Foryst-Ludwig A, Timm M, Rompe F, et al,. (2008). Angiotensin II type 2 receptor stimulation: a novel option of therapeutic interference with the renin-angiotensin system in myocardial infarction? Circulation 118: 2523-2532.
32. Kazama K, Anrather J, Zhou P, Girouard H, Frys K, Milner TA, et al,. (2004). Angiotensin II impairs neurovascular coupling in neocortex through NADPH oxidase-derived radicals. Circ Res 95: 1019-1026. (Pubitemid 39532332)
33. Kelly S, Bliss TM, Shah AK, Sun GH, Ma M, Foo WC, et al,. (2004). Transplanted human fetal neural stem cells survive, migrate, and differentiate in ischemic rat cerebral cortex. Proc Natl Acad Sci USA 101: 11839-11844. (Pubitemid 39095381)
34. Klotz L, Sastre M, Kreutz A, Gavrilyuk V, Klockgether T, Feinstein DL, et al,. (2003). Noradrenaline induces expression of peroxisome proliferator activated receptor gamma (PPARgamma) in murine primary astrocytes and neurons. J Neurochem 86: 907-916. (Pubitemid 36988803)
35. Kurtz TW, Klein U, (2009). Next generation multifunctional angiotensin receptor blockers. Hypertens Res 32: 826-834.
36. 2 receptor in the brain in regulation of blood pressure and water intake. Am J Physiol Heart Circ Physiol 284: H116-H121. (Pubitemid 36076277)
37. 2 receptor protects against cerebral ischemia-induced neuronal injury. FASEB J 19: 617-619. (Pubitemid 40471263)
38. 2 receptor-interacting protein and Src homology 2 domain-containing protein-tyrosine phosphatase 1. Mol Endocrinol 21: 499-511. (Pubitemid 46184898)
39. Li JM, Mogi M, Iwanami J, Min LJ, Tsukuda K, Sakata A, et al,. (2008). Temporary pretreatment with the angiotensin II type 1 receptor blocker, valsartan, prevents ischemic brain damage through an increase in capillary density. Stroke 39: 2029-2036.
40. Li NC, Lee A, Whitmer RA, Kivipelto M, Lawler E, Kazis LE, et al,. (2010). Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis. BMJ 340: b5465.
41. Liu R, Liu IY, Bi X, Thompson RF, Doctrow SR, Malfroy B, et al,. (2003). Reversal of age-related learning deficits and brain oxidative stress in mice with superoxide dismutase/catalase mimetics. Proc Natl Acad Sci USA 100: 8526-8531. (Pubitemid 36842578)
42. 2) receptor promotes axonal regeneration in the optic nerve of adult rats. J Exp Med 188: 661-670. (Pubitemid 28387929)
43. Luna-Medina R, Cortes-Canteli M, Alonso M, Santos A, Martinez A, Perez-Castillo A, (2005). Regulation of inflammatory response in neural cells in vitro by thiadiazolidinones derivatives through peroxisome proliferator- activated receptor gamma activation. J Biol Chem 280: 21453-21462. (Pubitemid 40805710)
44. Maeda K, Hata R, Bader M, Walther T, Hossmann KA, (1999). Larger anastomoses in angiotensinogen-knockout mice attenuate early metabolic disturbances after middle cerebral artery occlusion. J Cereb Blood Flow Metab 19: 1092-1098. (Pubitemid 30167759)
45. Mochizuki S, Dahlöf B, Shimizu M, Ikewaki K, Yoshikawa M, Taniguchi I, et al,.; Jikei Heart Study Group (2007). Valsartan in a Japanese population with hypertension and other cardiovascular disease (Jikei Heart Study): a randomized, open-label, blinded endpoint morbidity-mortality study. Lancet 369: 1431-1439. (Pubitemid 46635780)
46. Mogi M, Li JM, Iwanami J, Min LJ, Tsukuda K, Iwai M, et al,. (2006). Angiotensin II type-2 receptor stimulation prevents neural damage by transcriptional activation of methyl methanesulfonate sensitive 2. Hypertension 48: 141-148. (Pubitemid 44297536)
47. Morishita R, Kanda Y, Nakajima M, (2010). Irebesratn: second generation of ARB as Metabosartan. Curr Hypertens Rev 6: 173-179.
48. Nakamura T, Yamamoto E, Kataoka K, Yamashita T, Tokutomi Y, Dong YF, et al,. (2007). Pioglitazone exerts protective effects against stroke in stroke-prone spontaneously hypertensive rats, independently of blood pressure. Stroke 38: 3016-3022. (Pubitemid 350041562)
49. 2 receptor-interacting protein, ATIP. J Biol Chem 279: 28989-28997. (Pubitemid 38915768)
50. Reijmer YD, van den Berg E, Ruis C, Kappelle LJ, Biessels GJ, (2010). Cognitive dysfunction in patients with type 2 diabetes. Diabetes Metab Res Rev 26: 507-519.
51. 2 receptor and the transcription factor NF-kappaB. FASEB J 17: 2094-2096.
52. Rompe F, Artuc M, Hallberg A, Alterman M, Ströder K, Thöne-Reineke C, et al,. (2010). Direct angiotensin II type 2 receptor stimulation acts anti-inflammatory through epoxyeicosatrienoic acid and inhibition of nuclear factor kappaB. Hypertension 55: 924-931.
53. Saavedra JM, (2005). Brain angiotensin II: new developments, unanswered questions and therapeutic opportunities. Cell Mol Neurobiol 25: 485-512. (Pubitemid 41199709)
54. 1 receptor antagonists in the brain. Cell Mol Neurobiol 26: 1099-1111. (Pubitemid 44924033)
55. Schrader J, Lüders S, Kulschewski A, Hammersen F, Plate K, Berger J, et al,.; MOSES Study Group (2005). Morbidity and mortality after stroke, eprosartan compared with nitrendipine for secondary prevention: principal results of a prospective randomized controlled study (MOSES). Stroke 36: 1218-1226.
56. Schupp M, Janke J, Clasen R, Unger T, Kintscher U, (2004). Angiotensin type 1 receptor blockers induce peroxisome proliferator-activated receptor-gamma activity. Circulation 109: 2054-2057. (Pubitemid 38620211)
57. Shen LH, Li Y, Chen J, Zacharek A, Gao Q, Kapke A, et al,. (2007). Therapeutic benefit of bone marrow stromal cells administered 1 month after stroke. J Cereb Blood Flow Metab 27: 6-13. (Pubitemid 46006579)
58. 2 receptor-a matter of love and hate. Peptides 26: 1401-1149.
59. Sugawara A, Takeuchi K, Uruno A, Ikeda Y, Arima S, Kudo M, et al,. (2001). Transcriptional suppression of type 1 angiotensin II receptor gene expression by peroxisome proliferator-activated receptor-gamma in vascular smooth muscle cells. Endocrinology 142: 3125-3134. (Pubitemid 32575551)
60. Takeda K, Ichiki T, Tokunou T, Iino N, Takeshita A, (2001). 15-Deoxy-delta 12,14-prostaglandin J2 and thiazolidinediones activate the MEK/ERK pathway through phosphatidylinositol 3-kinase in vascular smooth muscle cells. J Biol Chem 276: 48950-48955.
61. Tham DM, Martin-McNulty B, Wang YX, Wilson DW, Vergona R, Sullivan ME, et al,. (2002). Angiotensin II is associated with activation of NF-kappaB-mediated genes and downregulation of PPARs. Physiol Genomics 11: 21-30. (Pubitemid 37128718)
62. Tsukuda K, Mog M, Iwanami J, Min LJ, Sakata A, Jing F, et al,. (2009). Cognitive deficit in amyloid-beta-injected mice was improved by pretreatment with a low dose of telmisartan partly because of peroxisome proliferator- activated receptor-gamma activation. Hypertension 54: 782-787.
63. Tureyen K, Kapadia R, Bowen KK, Satriotomo I, Liang J, Feinstein DL, et al,. (2007). Peroxisome proliferator-activated receptor-gamma agonists induce neuroprotection following transient focal ischemia in normotensive, normoglycemic as well as hypertensive and type-2 diabetic rodents. J Neurochem 101: 41-56. (Pubitemid 46426485)
64. Unger T, (2003). Inhibiting angiotensin receptors in the brain: possible therapeutic implications. Curr Med Res Opin 19: 449-451. (Pubitemid 36994451)
65. 2 receptor research and therapeutic potential. J Renin Angiotensin Aldosterone Syst 11: 75-77.
66. Vervoort VS, Beachem MA, Edwards PS, Ladd S, Miller KE, de Mollerat X, et al,. (2002). AGTR2 mutations in X-linked mental retardation. Science 296: 2401-2403. (Pubitemid 34734216)
67. Wada K, Nakajima A, Katayama K, Kudo C, Shibuya A, Kubota N, et al,. (2006). Peroxisome proliferator-activated receptor gamma-mediated regulation of neural stem cell proliferation and differentiation. J Biol Chem 281: 12673-12681. (Pubitemid 43855357)
68. Walther T, Olah L, Harms C, Maul B, Bader M, Hörtnagl H, et al,. (2002). Ischemic injury in experimental stroke depends on angiotensin II. FASEB J 16: 169-176. (Pubitemid 34113010)
69. Wan Y, Wallinder C, Plouffe B, Beaudry H, Mahalingam AK, Wu X, et al,. (2004). Design, synthesis, and biological evaluation of the first selective nonpeptide AT2 receptor agonist. J Med Chem 47: 5995-6008. (Pubitemid 39507341)
70. Wang N, Verna L, Chen NG, Chen J, Li H, Forman BM, et al,. (2002). Constitutive activation of peroxisome proliferator-activated receptor-gamma suppresses pro-inflammatory adhesion molecules in human vascular endothelial cells. J Biol Chem 277: 34176-34181.
71. Washida K, Ihara M, Nishio K, Fujita Y, Maki T, Yamada M, et al,. (2010). Nonhypotensive dose of telmisartan attenuates cognitive impairment partially due to peroxisome proliferator-activated receptor-gamma activation in mice with chronic cerebral hypoperfusion. Stroke 41: 1798-1806.
72. Wei Y, Whaley-Connell AT, Chen K, Habibi J, Uptergrove GM, Clark SE, et al,. (2007). NADPH oxidase contributes to vascular inflammation, insulin resistance, and remodeling in the transgenic (mRen2) rat. Hypertension 50: 384-391. (Pubitemid 47205789)
73. Willing AE, Lixian J, Milliken M, Poulos S, Zigova T, Song S, et al,. (2003). Intravenous versus intrastriatal cord blood administration in a rodent model of stroke. J Neurosci Res 73: 296-307. (Pubitemid 36918093)
74. 4 and their functions. Regul Pept 59: 269-295.
75. Wright JW, Reichert JR, Davis CJ, Hatding JW, (2002). Neural plasticity and the brain renin-angiotensin system. Neurosci Biobehav Rev 26: 529-552. (Pubitemid 35287231)
76. 2 receptor by a novel membrane-associated Golgi protein. Arterioscler Thromb Vasc Biol 25: 57-64. (Pubitemid 40054254)
77. Wu L, Iwai M, Nakagami H, Chen R, Suzuki J, Akishita M, et al,. (2001). Roles of angiotensin II type 2 receptor stimulation associated with selective angiotensin II type 1 receptor blockade with valsartan in the improvement of inflammation-induced vascular injury. Circulation 104: 2716-2721. (Pubitemid 33108140)
78. Wu L, Iwai M, Nakagami H, Chen R, Suzuki J, Akishita M, et al,. (2002). Effect of angiotensin II type 1 receptor blockade on cardiac remodeling in angiotensin II type 2 receptor null mice. Arterioscler Thromb Vasc Biol 22: 49-54. (Pubitemid 34076231)
79. Zhao Y, Foryst-Ludwig A, Bruemmer D, Culman J, Bader M, Unger T, et al,. (2005). Angiotensin II induces peroxisome proliferator-activated receptor gamma in PC12W cells via angiotensin type 2 receptor activation. J Neurochem 94: 1395-1401. (Pubitemid 41232594)
80. Zhao MZ, Nonoguchi N, Ikeda N, Watanabe T, Furutama D, Miyazawa D, et al,. (2006). Novel therapeutic strategy for stroke in rats by bone marrow stromal cells and ex vivo HGF gene transfer with HSV-1 vector. J Cereb Blood Flow Metab 26: 1176-1188. (Pubitemid 44268180)
81. 1 receptor blockade regulates the local angiotensin II system in cerebral microvessels from spontaneously hypertensive rats. Stroke 37: 1271-1276. (Pubitemid 43731875)
82. 2 receptor in the acute phase of stroke in rats. Neuroreport 11: 1191-1194. (Pubitemid 30262955)
83. Zhu X, Raina AK, Lee HG, Casadesus G, Smith MA, Perry G, (2004). Oxidative stress signaling in Alzheimer's disease. Brain Res 1000: 32-39. (Pubitemid 38446487)